Sponsored content from Golden Portfolio Right now, you can buy a dollar's worth of gold for about 36 cents.
That sounds impossible. Here's how it's real.
The major gold miners are throwing off record cash flow — even after gold's recent pullback. The four largest have never had this much free cash on hand. Ever. At today's gold price, they're running margins as high as 75% — the most profitable they have ever been.
Which hands them a problem.
Go here to see the problem — and why the majors are about to go on a shopping spree for the ages.
When a major gold miner makes record profits, it does one of two things: hand the cash back to shareholders, or buy the best junior mining assets to secure future production.
And here's the piece the market is missing:
The best junior assets are still priced as if gold were stuck at $1,800 an ounce — not north of $4,000, where it trades today.
So the majors are staring at their own future production shrinking, sitting on record cash, looking at top-tier junior assets trading at a fraction of what that gold is worth at today's price.
They don't have a choice. They buy — or their output keeps shrinking until they're out of business.
That's how you buy a dollar of gold for 36 cents: you own the junior before the major is forced to pay up for it.
The gap between what these assets are worth and what they trade for has a name. I call it the Golden Anomaly. It only appears early in a gold bull market, and it closes fast — usually the moment the majors start writing cheques.
So you can pay full price after the gap closes…
Or buy the dollar for 36 cents while the Anomaly still exists.
My name is Garrett Goggin, CFA, CMT, and it's why Porter Stansberry recently called me:
"THE most knowledgeable gold investor in the world."
Go here to see my Golden Anomaly portfolio — and the three names next on the majors' shopping list.
Best,
Garrett Goggin, CFA, CMT Lead Analyst and Founder, Golden Portfolio
More Reading from MarketBeat Media Flash in the Pan or Sustained Rally Contender? 3 Momentum Stocks to WatchSubmitted by Nathan Reiff. Originally Published: 8/22/2026. 
Key Points- Velo3D is attempting to turn improving revenue, margins and balance-sheet strength into a more durable recovery.
- Aehr Test Systems is benefiting from growing demand and repeat orders across several semiconductor end markets.
- Atlassian’s sharp rebound has put renewed attention on whether AI adoption and enterprise demand can sustain its momentum.
- Special Report: Here’s Why Trump Won’t End The Iran War

Momentum stocks have a natural appeal across Wall Street, but not every breakout turns into a lasting rally. Still, when companies are supported by improving earnings and fundamentals, expanding industries or other underlying strengths, they may be better positioned to convert a one-time share price boost into a longer-term trend.
Investors may be trying to make this determination about Velo3D Inc. (NASDAQ: VELO), Aehr Test Systems (NASDAQ: AEHR) and Atlassian Corp. (NASDAQ: TEAM). Each company has experienced a rally over the last month, although to very different degrees. Together, they show how varying catalysts—from restructuring efforts to broader technology trends and AI adoption—can initiate a breakout that may either be just getting started or prove difficult to maintain at its current pace. The key question for investors is whether these companies can sustain their recent growth.
Velo3D Crafts a Real Turnaround After Numerous Hurdles
A small Colorado company has secured rights to technology that could prevent the U.S. public power grid from collapsing — and billionaire Sam Altman is now an investor.
This under-the-radar firm is drawing serious attention from those watching the energy infrastructure space closely. Click here to learn this company's name for free today Velo3D is a metal 3D-printing technology firm that builds components for aerospace, defense and other specialized applications. In theory, Velo3D may be a good candidate as a tollbooth company because it can manufacture metal components that cannot be produced using traditional methods. However, the company has faced significant headwinds in recent years, including liquidity concerns and operational restructuring.
The firm may be in the early stages of a turnaround, though. Management's focus on boosting revenue—up 52.3% year over year (YOY) in the latest quarter—and gross margin while reducing debt may help stabilize the company's balance sheet. Debt fell by more than 70% in the latest quarter alone, suggesting that the company is making meaningful progress toward these goals. As an added benefit, Velo3D also raised both the low and high ends of its full-year revenue guidance by $5 million and now expects revenue to fall between $65 million and $75 million.
Despite these balance-sheet wins, it's important for investors to keep Velo3D's ongoing risks in mind. The company remains unprofitable, and that challenge persists even with improved liquidity. Still, marked improvements in short interest and a share price increase of nearly 19% over the last month—with analysts predicting roughly 65% more upside—may be enough to convince investors that the recent rally could continue.
Aehr's Risks Remain, But Growing Bookings and Demand Bode Well
Another company occupying a critical niche in a high-demand industry, Aehr Test Systems provides essential testing and burn-in equipment for semiconductors. As more AI processors are delivered to customers, the need for quality control grows, benefiting Aehr. Between growing bookings, an expanding backlog and continued demand across multiple end markets, Aehr has built significant momentum. Increasing follow-on production orders may also indicate that the company is successfully building a repeat customer base.
Shares are up over the last month, thanks to surging orders and the company's recent earnings report, which showed improved bookings and multiple large production orders. Still, the company is in a somewhat precarious financial position: Revenue fell 44% YOY last quarter, accompanied by a non-GAAP net loss of $1.5 million and a decline in gross margin. These factors prompted Aehr to raise capital through an at-the-market offering, which could dilute existing shareholders.
Atlassian's Recent Rally Is Impressive but May Be Hard to Maintain
Of all the stocks on this list, Atlassian has had the most dramatic breakout in recent weeks: Shares have surged more than 87% over the last month alone. As a key collaboration platform for enterprise customers, Atlassian has a key opportunity to integrate AI tools into its offerings.
The catalyst for the company's recent share price boost was its unusually strong fiscal Q4 results, which included impressive top- and bottom-line results and 28% YOY revenue growth. Bookings are as strong as ever, with Atlassian reporting record large-enterprise deals, while subscription annual recurring revenue climbed 23% YOY to $6.6 billion—a sign that the company's growth may be sustainable over time.
To be sure, analyst expectations for Atlassian are quite high, with 24 of 29 analysts rating TEAM a Buy. It may be difficult for the firm to continue posting results strong enough to sustain the rally seen in recent weeks. Investors may instead want to evaluate whether the latest updates suggest that Atlassian can convert interest in AI into sustainable revenue and demand over the medium to long term, then look for an opportunity to buy a future dip. |